Filtered By:
Cancer: Hepatocellular Carcinoma
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 36590 results found since Jan 2013.
Medical Treatment for Hepatocellular Carcinoma in Japan
J Nippon Med Sch. 2022 Jan 25. doi: 10.1272/jnms.JNMS.2022_89-224. Online ahead of print.ABSTRACTLiver cancer, including hepatocellular carcinoma (HCC), is the fifth most common cause of cancer deaths in Japan. The main treatment options for HCC are surgical resection, liver transplantation, radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and systemic chemotherapy. Here, recent medical treatments for HCC, including surgery, percutaneous ablation, transcatheter arterial chemoembolization/transcatheter arterial embolization, and drug therapy, are reviewed with a focus on Japan.PMID:35082203 | DOI:10.12...
Source: Journal of Nippon Medical School - January 27, 2022 Category: Universities & Medical Training Authors: Youichi Kawano Yohei Kaneya Yuto Aoki Masato Yoshioka Akira Matsushita Tetsuya Shimizu Junji Ueda Hideyuki Takata Nobuhiko Taniai Tomohiro Kanda Atsushi Hirakata Hideyuki Suzuki Hiroshi Yoshida Source Type: research
